Clinical Trials
INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...
News
I Holland Present their Latest Tablet Tooling Developments to a Virtual Audience at ACHEMA Pulse
I Holland, the world’s best-known manufacturer of tablet punches and dies for the pharmaceutical and nutraceutical industries, has announced it will be exhibiting some...
News
Vaccine Passports in NHS app unethical if they don’t allow date custodianship say FarmaTrust
FarmaTrust, the UK-based global medical supply chain data management provider – has warned that the UK is heading very rapidly down the wrong direction with...
News
DCGI approves anti-COVID drug developed by DRDO for emergency use
The Drugs Controller General of India has approved an anti-COVID oral drug, developed by DRDO, for emergency use as adjunct therapy in moderate to...
Press Releases
GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 for the Early Treatment of COVID-19
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the EMA has started a rolling review of data on sotrovimab, an investigational dual-action SARS-CoV-2 monoclonal...
News
Russia authorises use of single-dose Covid-19 vaccine Sputnik Light
Sputnik Light, which is based on the human adenoviral vector platform, is the first component, a recombinant human adenovirus serotype number 26 (rAd26), of...
Drug Research
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant
The protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2 strain. It is adjuvanted with the company’s saponin-based Matrix-M...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read